Viewing Study NCT07247266

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:36 PM
Ignite Modification Date: 2026-01-24 @ 12:50 PM
Study NCT ID: NCT07247266
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-01
First Post: 2025-11-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)
Sponsor: Akros Pharma Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cryopyrin-associated Periodic Syndromes (CAPS) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None JTE-162 View
None Efficacy View
None Safety View
None Tolerability View
None Cryopyrin-associated periodic syndromes View
None CAPS View
None Pharmacokinetics View